Harbor Investment Advisory’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.19K | Hold |
109
| – | – | ﹤0.01% | 1011 |
|
|
2025
Q1 | $4.22K | Hold |
109
| – | – | ﹤0.01% | 998 |
|
|
2024
Q4 | $3.69K | Buy |
109
+9
| +9% | +$304 | ﹤0.01% | 991 |
|
|
2024
Q3 | $4.09K | Hold |
100
| – | – | ﹤0.01% | 997 |
|
|
2024
Q2 | $3.85K | Sell |
100
-12
| -11% | -$462 | ﹤0.01% | 1000 |
|
|
2024
Q1 | $4.8K | Buy |
112
+8
| +8% | +$343 | ﹤0.01% | 980 |
|
|
2023
Q4 | $3.85K | Hold |
104
| – | – | ﹤0.01% | 974 |
|
|
2023
Q3 | $3.77K | Sell |
104
-222
| -68% | -$8.05K | ﹤0.01% | 959 |
|
|
2023
Q2 | $11.6K | Buy |
326
+105
| +48% | +$3.74K | ﹤0.01% | 999 |
|
|
2023
Q1 | $7.86K | Buy |
221
+22
| +11% | +$783 | ﹤0.01% | 1060 |
|
|
2022
Q4 | $6.99K | Buy |
199
+69
| +53% | +$2.43K | ﹤0.01% | 1065 |
|
|
2022
Q3 | $4K | Hold |
130
| – | – | ﹤0.01% | 1156 |
|
|
2022
Q2 | $7K | Sell |
130
-456
| -78% | -$24.6K | ﹤0.01% | 1090 |
|
|
2022
Q1 | $32K | Hold |
586
| – | – | ﹤0.01% | 844 |
|
|
2021
Q4 | $32K | Hold |
586
| – | – | ﹤0.01% | 847 |
|
|
2021
Q3 | $28K | Hold |
586
| – | – | ﹤0.01% | 886 |
|
|
2021
Q2 | $29K | Hold |
586
| – | – | ﹤0.01% | 838 |
|
|
2021
Q1 | $26K | Sell |
586
-36
| -6% | -$1.6K | ﹤0.01% | 834 |
|
|
2020
Q4 | $29K | Sell |
622
-36
| -5% | -$1.68K | ﹤0.01% | 749 |
|
|
2020
Q3 | $31K | Sell |
658
-180
| -21% | -$8.48K | 0.01% | 626 |
|
|
2020
Q2 | $43K | Hold |
838
| – | – | 0.01% | 464 |
|
|
2020
Q1 | $40K | Buy |
838
+180
| +27% | +$8.59K | 0.01% | 441 |
|
|
2019
Q4 | $39K | Buy |
+658
| New | +$39K | 0.01% | 448 |
|